long acting Injection [Design Issues]

posted by jag009  – NJ, 2020-04-21 23:06 (1901 d 22:00 ago) – Posting: # 21342
Views: 2,610

Hi,

❝ But if it is mentioned in monograph that half-life is 17 days following single dose and 46 days after multiple dose, then which half-life we should consider while designing multiple dose study? In the same monograph, it is also stated that steady state is achieved after 4th dose on injection.


Have you found out why the increase in half-life?

J

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,677 registered users;
28 visitors (0 registered, 28 guests [including 8 identified bots]).
Forum time: 21:07 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5